STOCK TITAN

[Form 4] Cidara Therapeutics, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Very Positive)
Form Type
4
Rhea-AI Filing Summary

Form 4 filing overview – The Hanover Insurance Group, Inc. (THG)

Executive Vice President Jeffrey M. Farber reported a routine, non-open-market acquisition of THG common stock on 27 June 2025. The transaction reflects the automatic issuance of 51.978 restricted stock units (RSUs) representing dividend-equivalent rights under the company’s 2022 Long-Term Incentive Plan. The RSUs were acquired at a stated price of $0.00 because they are dividend equivalents rather than market purchases. These units will vest on the third anniversary of the original RSU grant to which they relate.

Following this accrual, Farber’s direct beneficial ownership rises to 45,942.68 shares of THG common stock. No derivative securities were transacted, and no sales were reported.

Investment significance

  • The filing signals continued equity alignment by a senior executive, yet the incremental 52-share increase (≈0.1% of his holdings) is immaterial in absolute and relative terms.
  • Because the RSUs stem from routine dividend accruals and carry a standard three-year vesting schedule, the event is considered administrative rather than directional.

Panoramica della presentazione del Modulo 4 – The Hanover Insurance Group, Inc. (THG)

Il Vicepresidente Esecutivo Jeffrey M. Farber ha segnalato un'acquisizione di azioni ordinarie THG non di mercato e di routine in data 27 giugno 2025. La transazione riflette l'emissione automatica di 51,978 unità azionarie vincolate (RSU) che rappresentano diritti equivalenti ai dividendi nell'ambito del Piano Incentivi a Lungo Termine 2022 della società. Le RSU sono state acquisite a un prezzo nominale di $0,00 poiché si tratta di equivalenti di dividendi e non di acquisti di mercato. Queste unità matureranno al terzo anniversario della concessione originale delle RSU a cui si riferiscono.

A seguito di questa contabilizzazione, la proprietà diretta effettiva di Farber aumenta a 45.942,68 azioni ordinarie THG. Non sono stati effettuati scambi di strumenti derivati né segnalate vendite.

Significato dell'investimento

  • La presentazione indica un continuo allineamento azionario da parte di un dirigente senior, sebbene l'incremento di 52 azioni (circa lo 0,1% delle sue partecipazioni) sia irrilevante in termini assoluti e relativi.
  • Poiché le RSU derivano da accrediti di dividendi di routine e prevedono un normale periodo di maturazione di tre anni, l'evento è considerato amministrativo e non direzionale.

Resumen de la presentación del Formulario 4 – The Hanover Insurance Group, Inc. (THG)

El Vicepresidente Ejecutivo Jeffrey M. Farber reportó una adquisición rutinaria y fuera del mercado abierto de acciones comunes de THG el 27 de junio de 2025. La transacción refleja la emisión automática de 51.978 unidades restringidas de acciones (RSUs) que representan derechos equivalentes a dividendos bajo el Plan de Incentivos a Largo Plazo 2022 de la compañía. Las RSUs se adquirieron a un precio declarado de $0.00 porque son equivalentes a dividendos y no compras en el mercado. Estas unidades se consolidarán en el tercer aniversario de la concesión original de RSUs a la que están vinculadas.

Tras esta acumulación, la propiedad directa beneficiaria de Farber aumenta a 45,942.68 acciones comunes de THG. No se transaron valores derivados ni se reportaron ventas.

Importancia para la inversión

  • La presentación indica una continua alineación accionaria por parte de un ejecutivo senior, aunque el aumento incremental de 52 acciones (≈0.1% de sus tenencias) es insignificante en términos absolutos y relativos.
  • Dado que las RSUs provienen de acumulaciones rutinarias de dividendos y tienen un calendario estándar de consolidación de tres años, el evento se considera administrativo y no direccional.

Form 4 제출 개요 – The Hanover Insurance Group, Inc. (THG)

부사장 Jeffrey M. Farber2025년 6월 27일에 THG 보통주를 일상적이고 비공개 시장에서 취득했다고 보고했습니다. 이 거래는 회사의 2022년 장기 인센티브 계획에 따른 배당금 등가 권리를 나타내는 51.978개의 제한 주식 단위(RSU)의 자동 발행을 반영합니다. RSU는 배당금 등가물이므로 $0.00의 명시된 가격으로 취득되었습니다. 이 단위들은 원래 RSU 부여일로부터 3주년이 되는 날에 권리가 확정됩니다.

이 누적으로 인해 Farber의 직접적 실질 소유권은 THG 보통주 45,942.68주로 증가했습니다. 파생 증권 거래나 매도 보고는 없었습니다.

투자 의미

  • 이 제출은 고위 경영진의 지속적인 주식 정렬을 의미하지만, 52주 증가분(보유량의 약 0.1%)은 절대적 및 상대적으로 미미합니다.
  • RSU가 일상적인 배당 누적에서 발생하며 표준 3년 권리 확정 일정이 적용되므로, 이 사건은 방향성보다는 행정적인 것으로 간주됩니다.

Résumé du dépôt du formulaire 4 – The Hanover Insurance Group, Inc. (THG)

Le Vice-Président Exécutif Jeffrey M. Farber a déclaré une acquisition de routine, hors marché ouvert, d’actions ordinaires THG le 27 juin 2025. La transaction reflète l’émission automatique de 51,978 unités d’actions restreintes (RSU) représentant des droits équivalents aux dividendes dans le cadre du Plan d’Incitation à Long Terme 2022 de la société. Les RSU ont été acquises à un prix déclaré de 0,00 $ car il s’agit d’équivalents de dividendes et non d’achats sur le marché. Ces unités seront acquises à la date du troisième anniversaire de l’attribution initiale des RSU auxquelles elles se rapportent.

Suite à cet enregistrement, la possession directe bénéficiaire de Farber passe à 45 942,68 actions ordinaires THG. Aucun titre dérivé n’a été négocié et aucune vente n’a été signalée.

Signification pour l’investissement

  • Le dépôt indique un alignement continu des actions par un cadre supérieur, bien que l’augmentation incrémentielle de 52 actions (≈0,1 % de ses avoirs) soit négligeable en termes absolus et relatifs.
  • Comme les RSU proviennent d’accumulations de dividendes de routine et suivent un calendrier d’acquisition standard de trois ans, cet événement est considéré comme administratif plutôt que directionnel.

Überblick zur Form 4-Einreichung – The Hanover Insurance Group, Inc. (THG)

Executive Vice President Jeffrey M. Farber meldete am 27. Juni 2025 eine routinemäßige, nicht am offenen Markt erfolgte Erwerbung von THG-Stammaktien. Die Transaktion spiegelt die automatische Ausgabe von 51,978 Restricted Stock Units (RSUs) wider, die Dividendenäquivalente im Rahmen des langfristigen Anreizplans 2022 des Unternehmens darstellen. Die RSUs wurden zu einem angegebenen Preis von 0,00 $ erworben, da es sich um Dividendenäquivalente und nicht um Markttransaktionen handelt. Diese Einheiten werden am dritten Jahrestag der ursprünglichen RSU-Zuteilung, auf die sie sich beziehen, fällig.

Nach dieser Buchung erhöht sich Farbers direkter wirtschaftlicher Eigentumsanteil auf 45.942,68 Aktien der THG-Stammaktien. Es wurden keine Derivate gehandelt und keine Verkäufe gemeldet.

Bedeutung für die Investition

  • Die Einreichung signalisiert eine fortgesetzte Aktienausrichtung eines leitenden Managers, wobei der zusätzliche Anstieg um 52 Aktien (≈0,1 % seines Bestands) in absoluten und relativen Zahlen unerheblich ist.
  • Da die RSUs aus routinemäßigen Dividendengutschriften stammen und einen standardmäßigen dreijährigen Vesting-Zeitraum haben, wird das Ereignis als administrativ und nicht richtungsweisend eingestuft.
Positive
  • Insider stake increases—even if marginal—indicate continued alignment between executive compensation and shareholder value.
Negative
  • Immaterial volume: 51.978 shares (≈0.1% of existing stake) lacks signaling power for market direction.

Insights

TL;DR: Administrative RSU dividend accrual; immaterial impact.

The filing records 51.978 RSUs credited to EVP Jeffrey Farber through dividend-equivalent rights. With post-transaction ownership of 45,942.68 shares, the incremental award represents about 0.1% of his stake and does not alter insider sentiment or free-float dynamics. No cash outlay, no open-market activity, and no change in derivative exposure were disclosed. Investors should view this as routine compensation maintenance under the 2022 LTIP rather than a buy/sell signal.

TL;DR: Routine equity alignment, neutral governance signal.

The RSU dividend accrual aligns the executive’s compensation with shareholder returns, satisfying good governance practice. However, the tiny volume and automatic nature render it non-impactful for ownership structure or voting power. No red flags or preferential terms are evident; vesting mirrors the original grant’s three-year schedule. Governance implication: neutral.

Panoramica della presentazione del Modulo 4 – The Hanover Insurance Group, Inc. (THG)

Il Vicepresidente Esecutivo Jeffrey M. Farber ha segnalato un'acquisizione di azioni ordinarie THG non di mercato e di routine in data 27 giugno 2025. La transazione riflette l'emissione automatica di 51,978 unità azionarie vincolate (RSU) che rappresentano diritti equivalenti ai dividendi nell'ambito del Piano Incentivi a Lungo Termine 2022 della società. Le RSU sono state acquisite a un prezzo nominale di $0,00 poiché si tratta di equivalenti di dividendi e non di acquisti di mercato. Queste unità matureranno al terzo anniversario della concessione originale delle RSU a cui si riferiscono.

A seguito di questa contabilizzazione, la proprietà diretta effettiva di Farber aumenta a 45.942,68 azioni ordinarie THG. Non sono stati effettuati scambi di strumenti derivati né segnalate vendite.

Significato dell'investimento

  • La presentazione indica un continuo allineamento azionario da parte di un dirigente senior, sebbene l'incremento di 52 azioni (circa lo 0,1% delle sue partecipazioni) sia irrilevante in termini assoluti e relativi.
  • Poiché le RSU derivano da accrediti di dividendi di routine e prevedono un normale periodo di maturazione di tre anni, l'evento è considerato amministrativo e non direzionale.

Resumen de la presentación del Formulario 4 – The Hanover Insurance Group, Inc. (THG)

El Vicepresidente Ejecutivo Jeffrey M. Farber reportó una adquisición rutinaria y fuera del mercado abierto de acciones comunes de THG el 27 de junio de 2025. La transacción refleja la emisión automática de 51.978 unidades restringidas de acciones (RSUs) que representan derechos equivalentes a dividendos bajo el Plan de Incentivos a Largo Plazo 2022 de la compañía. Las RSUs se adquirieron a un precio declarado de $0.00 porque son equivalentes a dividendos y no compras en el mercado. Estas unidades se consolidarán en el tercer aniversario de la concesión original de RSUs a la que están vinculadas.

Tras esta acumulación, la propiedad directa beneficiaria de Farber aumenta a 45,942.68 acciones comunes de THG. No se transaron valores derivados ni se reportaron ventas.

Importancia para la inversión

  • La presentación indica una continua alineación accionaria por parte de un ejecutivo senior, aunque el aumento incremental de 52 acciones (≈0.1% de sus tenencias) es insignificante en términos absolutos y relativos.
  • Dado que las RSUs provienen de acumulaciones rutinarias de dividendos y tienen un calendario estándar de consolidación de tres años, el evento se considera administrativo y no direccional.

Form 4 제출 개요 – The Hanover Insurance Group, Inc. (THG)

부사장 Jeffrey M. Farber2025년 6월 27일에 THG 보통주를 일상적이고 비공개 시장에서 취득했다고 보고했습니다. 이 거래는 회사의 2022년 장기 인센티브 계획에 따른 배당금 등가 권리를 나타내는 51.978개의 제한 주식 단위(RSU)의 자동 발행을 반영합니다. RSU는 배당금 등가물이므로 $0.00의 명시된 가격으로 취득되었습니다. 이 단위들은 원래 RSU 부여일로부터 3주년이 되는 날에 권리가 확정됩니다.

이 누적으로 인해 Farber의 직접적 실질 소유권은 THG 보통주 45,942.68주로 증가했습니다. 파생 증권 거래나 매도 보고는 없었습니다.

투자 의미

  • 이 제출은 고위 경영진의 지속적인 주식 정렬을 의미하지만, 52주 증가분(보유량의 약 0.1%)은 절대적 및 상대적으로 미미합니다.
  • RSU가 일상적인 배당 누적에서 발생하며 표준 3년 권리 확정 일정이 적용되므로, 이 사건은 방향성보다는 행정적인 것으로 간주됩니다.

Résumé du dépôt du formulaire 4 – The Hanover Insurance Group, Inc. (THG)

Le Vice-Président Exécutif Jeffrey M. Farber a déclaré une acquisition de routine, hors marché ouvert, d’actions ordinaires THG le 27 juin 2025. La transaction reflète l’émission automatique de 51,978 unités d’actions restreintes (RSU) représentant des droits équivalents aux dividendes dans le cadre du Plan d’Incitation à Long Terme 2022 de la société. Les RSU ont été acquises à un prix déclaré de 0,00 $ car il s’agit d’équivalents de dividendes et non d’achats sur le marché. Ces unités seront acquises à la date du troisième anniversaire de l’attribution initiale des RSU auxquelles elles se rapportent.

Suite à cet enregistrement, la possession directe bénéficiaire de Farber passe à 45 942,68 actions ordinaires THG. Aucun titre dérivé n’a été négocié et aucune vente n’a été signalée.

Signification pour l’investissement

  • Le dépôt indique un alignement continu des actions par un cadre supérieur, bien que l’augmentation incrémentielle de 52 actions (≈0,1 % de ses avoirs) soit négligeable en termes absolus et relatifs.
  • Comme les RSU proviennent d’accumulations de dividendes de routine et suivent un calendrier d’acquisition standard de trois ans, cet événement est considéré comme administratif plutôt que directionnel.

Überblick zur Form 4-Einreichung – The Hanover Insurance Group, Inc. (THG)

Executive Vice President Jeffrey M. Farber meldete am 27. Juni 2025 eine routinemäßige, nicht am offenen Markt erfolgte Erwerbung von THG-Stammaktien. Die Transaktion spiegelt die automatische Ausgabe von 51,978 Restricted Stock Units (RSUs) wider, die Dividendenäquivalente im Rahmen des langfristigen Anreizplans 2022 des Unternehmens darstellen. Die RSUs wurden zu einem angegebenen Preis von 0,00 $ erworben, da es sich um Dividendenäquivalente und nicht um Markttransaktionen handelt. Diese Einheiten werden am dritten Jahrestag der ursprünglichen RSU-Zuteilung, auf die sie sich beziehen, fällig.

Nach dieser Buchung erhöht sich Farbers direkter wirtschaftlicher Eigentumsanteil auf 45.942,68 Aktien der THG-Stammaktien. Es wurden keine Derivate gehandelt und keine Verkäufe gemeldet.

Bedeutung für die Investition

  • Die Einreichung signalisiert eine fortgesetzte Aktienausrichtung eines leitenden Managers, wobei der zusätzliche Anstieg um 52 Aktien (≈0,1 % seines Bestands) in absoluten und relativen Zahlen unerheblich ist.
  • Da die RSUs aus routinemäßigen Dividendengutschriften stammen und einen standardmäßigen dreijährigen Vesting-Zeitraum haben, wird das Ereignis als administrativ und nicht richtungsweisend eingestuft.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
RA CAPITAL MANAGEMENT, L.P.

(Last) (First) (Middle)
200 BERKELEY STREET, 18TH FLOOR

(Street)
BOSTON MA 02116

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Cidara Therapeutics, Inc. [ CDTX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/26/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/26/2025 P 2,272,727 A $44 3,365,523 I See footnotes(1)(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
RA CAPITAL MANAGEMENT, L.P.

(Last) (First) (Middle)
200 BERKELEY STREET, 18TH FLOOR

(Street)
BOSTON MA 02116

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
X Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
RA Capital Healthcare Fund LP

(Last) (First) (Middle)
200 BERKELEY STREET, 18TH FLOOR

(Street)
BOSTON MA 02116

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
X Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Kolchinsky Peter

(Last) (First) (Middle)
C/O RA CAPITAL MANAGEMENT, L.P.
200 BERKELEY STREET, 18TH FLOOR

(Street)
BOSTON MA 02116

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
X Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Shah Rajeev M.

(Last) (First) (Middle)
C/O RA CAPITAL MANAGEMENT, L.P.
200 BERKELEY STREET, 18TH FLOOR

(Street)
BOSTON MA 02116

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
X Director X 10% Owner
Officer (give title below) Other (specify below)
Explanation of Responses:
1. RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein.
2. Held directly by the Fund.
Remarks:
Joshua Resnick, a Partner of the Adviser, serves on the Issuer's board of directors.
/s/ Peter Kolchinsky, Manager of RA Capital Management, L.P. 06/30/2025
/s/ Peter Kolchinsky, Manager of RA Capital Healthcare Fund GP, LLC the General Partner of RA Capital Healthcare Fund, L.P. 06/30/2025
/s/ Peter Kolchinsky, individually 06/30/2025
/s/ Rajeev Shah, individually 06/30/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many THG shares did EVP Jeffrey Farber acquire on 27 June 2025?

He was credited with 51.978 restricted stock units as dividend equivalents.

What is Jeffrey Farber’s total THG ownership after the transaction?

His direct beneficial ownership stands at 45,942.68 shares.

Was any cash paid for the newly acquired THG shares?

No. The RSUs were issued at $0.00 because they reflect dividend-equivalent rights.

When will the acquired RSUs vest?

They vest on the third anniversary of the original underlying RSU grant date.

Does this Form 4 indicate insider buying or selling in the open market?

No. The filing records an automatic, non-open-market accrual of RSUs; no purchases or sales occurred.
Cidara Theraptcs

NASDAQ:CDTX

CDTX Rankings

CDTX Latest News

CDTX Latest SEC Filings

CDTX Stock Data

1.03B
19.94M
1.38%
69.43%
2.17%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
SAN DIEGO